These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 9493120)

  • 21. Combined treatment with ibuprofen and the AT1 receptor antagonist candesartan in young spontaneously hypertensive rats.
    Pollock DM; Morsing P
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S116-9. PubMed ID: 9892151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
    Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
    Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
    Kim S; Zhan Y; Izumi Y; Iwao H
    Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
    Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.
    Yamakawa H; Jezova M; Ando H; Saavedra JM
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):371-80. PubMed ID: 12621312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension.
    Inada Y; Murakami M; Kaido K; Nakao K
    Arzneimittelforschung; 1999 Jan; 49(1):13-21. PubMed ID: 10028373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist].
    Inada Y; Naka T
    Nihon Yakurigaku Zasshi; 2000 Mar; 115(3):151-60. PubMed ID: 10876800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glomerular dimensions in spontaneously hypertensive rats: effects of AT1 antagonism.
    Kett MM; Alcorn D; Bertram JF; Anderson WP
    J Hypertens; 1996 Jan; 14(1):107-13. PubMed ID: 12013482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
    Brown L; Duce B; Miric G; Sernia C
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil.
    Unger T
    Blood Press Suppl; 2000; 1():14-8. PubMed ID: 11059630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
    Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
    Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats.
    Cervenka L; Wang CT; Navar LG
    Am J Physiol; 1998 May; 274(5):F940-5. PubMed ID: 9612332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
    Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
    J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury.
    Bregonzio C; Armando I; Ando H; Jezova M; Baiardi G; Saavedra JM
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G414-23. PubMed ID: 12686508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
    Obata J; Nakamura T; Kuroyanagi R; Yoshida Y; Guo DF; Inagami T
    Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats.
    Yoshimoto T; Naruse M; Naruse K; Shionoya K; Tanaka M; Tanabe A; Hagiwara H; Hirose S; Muraki T; Demura H
    Endocrinology; 1996 Mar; 137(3):1102-7. PubMed ID: 8603580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.
    Welch WJ; Wilcox CS
    Kidney Int; 2001 Apr; 59(4):1257-63. PubMed ID: 11260386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.